Retension Pharmaceuticals. Inc.
Clinical trials sponsored by Retension Pharmaceuticals. Inc., explained in plain language.
-
New pill shows promise for lowering blood pressure in early trial
Disease control CompletedThis study tested an experimental drug called SLx-2101 in 38 adults with moderate to severe high blood pressure. Participants took either 5 mg or 10 mg of the drug daily for 14 days to see how it affected their blood pressure and heart rate. The goal was to check if the drug is s…
Phase: PHASE2 • Sponsor: Retension Pharmaceuticals. Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New hypertension drug shows promise in early trial
Disease control CompletedThis study tested a new drug called SLx-2101 in 26 adults with moderate to severe high blood pressure. Participants took the pill once daily for up to 12 days to see how well it lowers blood pressure and if it is safe. The goal is to find the right dose for future studies.
Phase: PHASE2 • Sponsor: Retension Pharmaceuticals. Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC